Skip to main content
. 2016 May 1;10(5):OC27–OC31. doi: 10.7860/JCDR/2016/17948.7792

[Table/Fig-12]:

Compliance with opportunistic infection prophylaxis/ treatment.

Opportunistic infection Drugs No. of patients Compliance (mean±S.D)
PJP prophylaxis Cotrimoxazole-DS 63 88.97± 23.75
PJP treatment Cotrimoxazole-DS 4 84.12±14.21
Tuberculosis treatment ATT under DOTS 3 100
Oropharyngeal candidiasis Fluconazole 3 100